Uptravi 1,600 MCG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FX2BF
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,298
Award facts
- Contract value 100% obligated
- $36,297.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $36,297.66 by the Defense Logistics Agency (DLA) on August 7, 2025, for the supply of UPTRAVI 1,600 MCG tablets (60-count packaging). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 28, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities worldwide.
UPTRAVI, a pulmonary hypertension treatment, is one of many specialized pharmaceuticals that DMS Pharmaceutical Group supplies to federal agencies through its established distribution network. The company has built a robust federal contract portfolio delivering branded and generic prescription drugs, biologics, and medical consumables to military health facilities across the nation. As a consistent performer in DLA pharmaceutical procurement, DMS Pharmaceutical Group leverages its small business status and specialized expertise to provide critical pharmaceutical supply chain support to Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FX2BF?
SPE2DB25FX2BF was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 7, 2025.
How much is contract SPE2DB25FX2BF worth?
The government has obligated $36,298 on SPE2DB25FX2BF.
Is contract SPE2DB25FX2BF an order under another contract?
Yes. SPE2DB25FX2BF is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB25FX2BF competed?
The extent of competition for SPE2DB25FX2BF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award